A view of the ExxonMobil Baton Rouge Refinery in Baton Rouge, Louisiana, May 15, 2021. Kathleen Flynn | Reuters Engine No. 1, the upstart activist firm that put three candidates on Exxon’s board of directors, is launching an exchange-traded fund in a bet that shareholder activism will take center stage in coming years. The Engine
admin
In this article GME SBH RCL CRWD PTON COIN A Peloton Interactive Inc. logo on a stationary bike at the company’s showroom in Dedham, Massachusetts, U.S., on Wednesday, Feb. 3, 2021. Adam Glanzman | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Peloton — Shares of the stationary bike company
Last month I wrote about the upcoming spinoff at AT&T (NYSE:T). It has not announced how much the exact dividend cut (“nearly 50%“) will be and the deal is still a year off. Since then, T stock has fallen about 3% from $29.55 to $28.65 as of last week’s close. But it still does not
Berkshire Hathaway (NYSE:BRK-A, NYSE:BRK-B) has usually been right when it comes to investing in long-term value creators. Among Berkshire Hathaway’s investments are a growing portfolio of companies that are in the business of geothermal power. As clean energy grows more prominent, knowing which geothermal stocks will be winners is critical. Berkshire also points out that
Clover Health (NASDAQ:CLOV) stock is up 57% in the last month. The price action highlights the uncertainty of investing in celebrity SPAC (special purpose acquisition company) plays. Source: Shutterstock Bit of background here. Venture capitalist and resident SPAC king Chamath Palihapitiya helped Clover, which sells Medicare-backed insurance plans, to go public through a $3.7 billion deal
It’s fair to say that Inovio Pharmaceuticals (NASDAQ:INO) wasn’t the first or most famous entrant into the Covid-19 vaccine race. Nevertheless, there are reasons to be bullish on INO stock. Source: Ascannio / Shutterstock.com It’s unfair to pigeonhole INO stock as “just a Covid stock.” Inovio remains on the cutting edge of DNA science with 15
Representations of the Bitcoin cryptocurrency are seen in this illustration picture taken June 7, 2021. Egdar Su | Reuters MicroStrategy said Monday it owns more than 100,000 bitcoins after completing another purchase round, this time spending roughly $489 million on 13,005 tokens. Shares of the Virginia-based enterprise software company were down more than 6% in
In this article SAFM GSAT FANG PPC A worker wearing a protective mask fulfills an online order at a Stew Leonard’s supermarket in Paramus, New Jersey, on Tuesday, May 12, 2020. Stew Leonard Jr. said that the meatpacking plant the company uses is operating at about 70% capacity, and he expects it to rebound to
In an ideal world, you get to work in a palatial, heavenly setting while you pursue your professional dreams of being a chief financial officer (CFO), controller, investment banking executive, or a private equity partner. Saint Peter (better known as human resources) lets you pass through the pearly gates with ease during interviews and you
IBM (NYSE:IBM) produced stellar first-quarter earnings on Apr. 19, with huge implications for the stock. Most importantly, the company’s cloud-based software earnings are now on a clear recurring growth path. I estimate IBM stock is now worth at least one-fourth more at $183 per share. Moreover, the stock is also cheap. Source: shutterstock.com/LCV IBM’s revenue
I’ve been wrong twice about DraftKings (NASDAQ:DKNG) stock. I may be again. In June 2020, six months after DraftKings came public, I warned people to look out below. At the time the stock was at $42/share. It has since traded for as much as $72/share. In January 2021 I suggested there was still time to
After an euphoric rally to $64.9 earlier this year, Churchill Capital Corp IV (NYSE:CCIV) stock has seen a sharp correction. While the stock seems to be consolidating around $20 levels, CCIV stock has struggled to break-out on the upside. Source: gg5795 / Shutterstock.com There are two likely reasons for the correction and the stock sustaining
CNBC’s Jim Cramer said Monday he’s offloaded most of his bitcoin holdings, expressing concerns around the recent crackdown on crypto mining by the Chinese government and bitcoin’s role in some ransomware attacks. “Sold almost all of my bitcoin. Don’t need it,” Cramer said on “Squawk on the Street,” more than two months after he first
In this article GSBD ACI Rafael Henrique | LightRocket | Getty Images Check out the companies making headlines in midday trading. DoorDash — Shares of DoorDash added about 5% after the food delivery company announced a partnership with Albertsons on same-day grocery delivery from nearly 2,000 stores. “Leveraging our extensive logistics network and Albertsons’ wide
This article will look at three of our favorite ways for investors to profit from a rising housing market. These are not homebuilder stocks, but instead represent companies that have business models that will benefit from continued growth in home construction and new and existing home sales. This list includes two companies that have overcome
Growth stocks, which took a back seat to their value counterparts from January through May of this year, have been bouncing back in the past month. For example, the S&P SPDR 500 Growth ETF (NYSEARCA:SPYG) is up 5% in the past month, compared to a 3% loss for the S&P SPDR 500 Value ETF (NYSEARCA:SPYV).
MicroVision is still up for sale, just like the CEO said it was and the latest 10-Q report indicates. Unfortunately, there are still no buyers. Source: Shutterstock For some reason, the market thinks a deal will happen when the stock is at a market value of $3.41 billion. Allow me to provide an evidently-needed reality
A meme stock with huge earnings and strong fundamentals? Pretty rare, right? Well, let me introduce you to UWM Holdings (NYSE:UWMC). UWMC stock is the rare one where both Reddit traders and value investors can unite. The shares are cheap, the business is booming and social media is all over the stock. Source: Shutterstock The market
A good financial advisor acts as a fiduciary who can help you with various financial tasks such as estate planning and investing. If your financial advisor is not meeting your expectations, it might be time for a new one. Breaking up can be hard to do. That’s particularly true when it comes to your financial
We’ve been pounding the table on Lucid Motors and Churchill Capital (NYSE:CCIV), the SPAC behind Lucid Motors, for a while now. We believe the company is in a prime position to steal significant market share from Tesla in the premium electric vehicle (EV) category over the next few years. Source: ggTravelDiary / Shutterstock.com Consequently, it’s a
Canoo (NASDAQ:GOEV) released its earnings on May 17 and made some concerning statements. Expect GOEV stock to drive lower. Source: Shutterstock For starters, the company is no longer going to use a contract manufacturer. It also expects to take until 2023 before electric vehicle (EV) deliveries and revenue begin to flow into the company. More troubling
QuantumScape (NYSE:QS) stock supports a next-generation battery technology developer aiming to revolutionize the EV charging sector with solid-state batteries. Source: Michael Vi / Shutterstock.com Despite its pre-revenue status, QuantumScape is well-funded and continues to execute its plans effectively to gain the confidence of its stockholders. Although several risks remain with its business, it is doing
Stewie the Yorkie Chihuahua is seen outside the New York Stock Exchange ahead of the IPO for Chewy Inc., June 14, 2019. Andrew Kelly | Reuters Given the current financial landscape, how can investors spot compelling plays? One strategy is to look for stocks that boast strong upside potential through 2021 and beyond. The names
Take a look at some of the biggest movers in the premarket: CureVac (CVAC) – CureVac shares plunged 46.2% in the premarket after the German drugmaker reported disappointing results from a study of its experimental Covid-19 vaccine. The treatment was 47% effective in a clinical trial, compared to more than 90% for other mRNA-based vaccines
I ‘m still very upbeat on Arrival (NASDAQ:ARVL) and ARVL stock, due to the electric vehicle maker’s pioneering, low-cost manufacturing process and its huge partnership with UPS (NYSE:UPS). Source: Shutterstock Further, I think that other pundits and the financial news media may have been incorrect when they claimed that the stock’s recent surge was entirely
Since the beginning of the year, shares of Cyprus-based shipping company Castor Maritime (NASDAQ:CTRM) stock are up by more than 80%. Source: Pavel Kapysh / Shutterstock.com As stated in its filings with the SEC back in April, its recent stock increases were “significantly inconsistent” with its performance. It continues to expand its fleet aggressively, putting
With so much enthusiasm baked into the equities sector, many investors undoubtedly feel that now is a time to consider a risk-off profile. Frankly, I agree with these folks. That said, we’re coming off the (hopefully) worst of the novel coronavirus pandemic. Therefore, others believe that the best days are still ahead of us. If
Federal Reserve Chair Jerome Powell speaks during a Senate Banking Committee hearing on Capitol Hill, Washington, December 1, 2020. Al Drago | Pool | Reuters The Federal Reserve unleashed a huge repositioning in global financial markets, as investors reacted to a world where the U.S. central bank is no longer guaranteeing that its policies will
If one were to poll investors and investment professionals to determine their ideal investment scenario, the vast majority would no doubt agree: It’s a double-digit total return in all economic environments, each and every year. Naturally, they would also agree that the worst-case scenario is an overall decrease in asset value. But despite this knowledge,
Social momentum is not a permanent driving force. It causes stocks to rise, but it can’t sustain stocks at unprecedented levels all on its own. Once hype dies, meme stocks go down. If a company caught up in this kind of trading isn’t solid on its own, its stock goes down … a lot. For